Shanghai Sanyou Medical Co., Ltd acquires its controlling subsidiary at a 4 times premium, with the necessity of the Trade and performance commitments being key points of inquiry.

① Shanghai Sanyou Medical Co., Ltd intends to acquire the remaining shares of its subsidiary, Shuimu Tianpeng. An assessment indicates that Shuimu Tianpeng's value has increased by 0.693 billion yuan, with a value increase rate of 406.21%. ② Shanghai Sanyou Medical Co., Ltd stated that the acquisition is beneficial for enhancing the company's overall profitability. Prior to the acquisition, Shanghai Sanyou Medical Co., Ltd had consistently faced declining performance.

cls.cnDec 17, 2024 05:18 ET

Zhende Medical: The US tariff policy has no impact on the company yet, and the Mexican production base may be completed next year | Direct hit on earnings conference

①Zhende Medical's chairman Lu Jianguo introduced at the earnings conference that the construction of the new production base in Mexico is expected to be completed next year; ② Zhende Medical explained the company's Q3 operation situation, with further decrease in revenue from isolation protective equipment.

cls.cnNov 25, 2024 04:56 ET

Stocks are hitting the ceiling! Since October, 10 A-share listed companies have announced being targeted, with china national medicines corporation and sh pharma being targeted on the same day by new china life insurance.

① According to incomplete statistics, since October, 10 A-share listed companies including zhejiang east crystal electronic, semiconductor manufacturing international corporation, quanjinhao, lifecome biochemistry, zhejiang jingu, primeton information technologies, inc., guangzhou goaland energy conservation tech, xuzhou handler special vehicle, china national medicines corporation, and sh pharma have announced that they have received major stock purchases from relevant parties (see attached table). ② In the secondary market, this week, xuzhou handler special vehicle and guangzhou goaland energy conservation tech have both seen their stock prices increase by more than 100% since September.

cls.cnNov 17, 2024 02:30 ET

Long-serving senior executive of lepu medical technology resigns, can the second generation successor stop the decline in performance? | Express announcement

①Tonight, lepu medical technology announced that General Manager Zhang Zhibin and Deputy General Manager Zheng Guorui resigned, and the Chairman's daughter Pu Fei took over as General Manager, with a "sea turtle elite" background; ②Starting from 2023, lepu medical technology's performance has declined for several consecutive quarters, and the market cap has dropped by one quarter compared to its peak period.

cls.cnSep 25, 2024 11:34 ET

Intends to acquire medical instruments dealer micro-tech for 0.29 billion, accelerating its overseas expansion.

①CME is a channel company for the sale of medical equipment products located in Europe, with sales advantages in products such as endoscopy. ②In recent years, to offset the domestic impact, micro-tech's overseas income has gradually increased, reaching 0.624 billion yuan in the first half of 2024, accounting for 46.78% of the overall income.

cls.cnSep 19, 2024 03:52 ET

Zhende Medical: Isolation protection product gross margin decreased by more than 6 percentage points. Slow progress in the development of artificial leather has been questioned. | Directly impacting earnings conference

At the zhende medical earnings conference, the company's research and development issues have attracted investors' attention. The company's CFO, Jin Haiping, introduced that the gross margin of the company's isolation and protective equipment in the first half of the year decreased by 6.07 percentage points compared to the same period last year. The company's secretary, Ji Baohai, said that the United States' further increase in tariffs on masks and other products has no impact on the company.

cls.cnSep 18, 2024 05:47 ET